本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioAge Labs Inc.

4.55
+0.09002.02%
盤後4.550.00000.00%18:41 EDT
成交量:19.73萬
成交額:88.47萬
市值:1.63億
市盈率:-1.60
高:4.60
開:4.50
低:4.40
收:4.46
52周最高:26.62
52周最低:2.88
股本:3,585.00萬
流通股本:2,382.00萬
量比:2.73
換手率:0.83%
股息:- -
股息率:- -
每股收益(TTM):-2.8421
每股收益(LYR):-6.6293
淨資產收益率:-35.88%
總資產收益率:-23.46%
市淨率:0.55
市盈率(LYR):-0.69

資料載入中...

2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/06/09

重要事件披露

Form 8-K - Current report
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/20

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/04

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/30

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/27

重要事件披露

Form 8-K - Current report
2024/09/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/25

SEC問詢函

Form CORRESP - Correspondence
2024/09/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]